0001225208-18-015733.txt : 20181120
0001225208-18-015733.hdr.sgml : 20181120
20181120174004
ACCESSION NUMBER: 0001225208-18-015733
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20181119
FILED AS OF DATE: 20181120
DATE AS OF CHANGE: 20181120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manders Matthew G
CENTRAL INDEX KEY: 0001480601
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08323
FILM NUMBER: 181196449
MAIL ADDRESS:
STREET 1: 1601 CHESTNUT STREET
STREET 2: TWO LIBERTY PLACE
CITY: PHILADELPHIA
STATE: PA
ZIP: 19192
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CIGNA CORP
CENTRAL INDEX KEY: 0000701221
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 061059331
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
BUSINESS PHONE: 8602266000
MAIL ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
FORMER COMPANY:
FORMER CONFORMED NAME: Cigna Corp
DATE OF NAME CHANGE: 20111019
FORMER COMPANY:
FORMER CONFORMED NAME: CIGNA CORP
DATE OF NAME CHANGE: 19920703
3
1
doc3.xml
X0206
3
2018-11-19
0
0000701221
CIGNA CORP
CI
0001480601
Manders Matthew G
900 COTTAGE GROVE ROAD
BLOOMFIELD
CT
06002
1
President, Strategy & Solution
Common Stock, $.25 Par Value
35425.0000
D
Employee Stock Option (Right to Buy)
78.0350
2015-02-26
2024-02-26
Common Stock, $.25 Par Value
39038.0000
D
Employee Stock Option (Right to Buy)
120.8950
2016-02-25
2025-02-25
Common Stock, $.25 Par Value
30229.0000
D
Employee Stock Option (Right to Buy)
139.2200
2017-03-01
2026-03-01
Common Stock, $.25 Par Value
34035.0000
D
Employee Stock Option (Right to Buy)
149.1350
2018-02-28
2027-02-28
Common Stock, $.25 Par Value
28038.0000
D
This option is fully vested.
Exhibit List: Exhibit 24 - Power of Attorney poamanders.txt
By: Jill M. Stadelman, attorney-in-fact
2018-11-20
EX-24
2
poamanders.txt
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, an Officer of Cigna
Corporation, a Delaware corporation ("Cigna"), hereby makes, designates,
constitutes and appoints NICOLE S. JONES, NEIL BOYDEN TANNER, AMY COOK, JILL
STADELMAN, and MARGUERITE GEIGER each acting individually, as the undersigned's
true and lawful attorneys-in-fact and agents, with full power and authority to
act in the undersigned's capacity as a director of Cigna for and in the name,
place and stead of the undersigned to execute and deliver:
(A) in connection with the filing with the Securities and Exchange Commission
pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934,
both as amended, of:
(i) Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934, Forms 144 in accordance with Rule 144 promulgated under
the Securities Act of 1933 and any and all other documents related thereto
(including, but not limited to, Seller's Representation Letters) and to take
further action as they, or any of them, deem appropriate in connection with the
foregoing.
Such attorneys-in-fact and agents, or any of them, are also hereby granted full
power and authority, on behalf of and in the name, place and stead of the
undersigned, to execute and deliver any and all such other documents, and to
take further action as they, or any of them, deem appropriate in connection with
the foregoing. The powers and authorities granted herein to such
attorneys-in-fact and agents, and each of them, also include the full right,
power and authority to effect necessary or appropriate substitutions or
revocations.
The undersigned hereby ratifies, confirms, and adopts, as his or her own act
and deed, all action lawfully taken by such attorneys-in-fact and agents, or any
of them, or by their respective substitutes, pursuant to the powers and
authorities herein granted. This Power of Attorney with respect to Forms 3, 4,
5 and 144 shall remain in full force and effect until:, the undersigned no
longer has responsibilities relating to Section 16 of the Securities Exchange
Act of 1934 or Rule 144 promulgated under the Securities Act of 1933 with
respect to the undersigned's beneficial ownership of securities of Cigna, unless
earlier revoked by the undersigned in a signed writing to each such attorney
in fact.
IN WITNESS WHEREOF, the undersigned has executed this document as of
the 14th day of November, 2018.
/s/ Matthew G. Manders
Signature
Matthew G. Manders
Print Name